{"id":42705,"date":"2023-11-14T19:57:33","date_gmt":"2023-11-14T19:57:33","guid":{"rendered":"https:\/?p=42705"},"modified":"2023-11-14T19:57:33","modified_gmt":"2023-11-14T19:57:33","slug":"american-analyst-ratings-november-14th-allk-bntx-fsr-gild-feem-nutx-zs","status":"publish","type":"post","link":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-14th-allk-bntx-fsr-gild-feem-nutx-zs\/","title":{"rendered":"American Analyst Ratings November 14th (ALLK) (BNTX) (FSR) (GILD) (FEEM) (NUTX) (ZS)"},"content":{"rendered":"

US Analysts Ratings Roundup<\/a><\/h2>\n

Abivax SA American Depositary Shares ABVX Leerink Swann Initiated Outperform 20
\nAbivax SA American Depositary Shares ABVX Morgan Stanley & Co. Initiated Equal-Weight 15
\nAbivax SA American Depositary Shares ABVX SVB Leerink Initiated by Outperform 20
\nAdient PLC ADNT Morgan Stanley & Co. Target Lowered by Underweight – Underweight 35
\nAmerican Eagle Outfitters Inc AEO Telsey Advisory Group Reiterated by Market Perform – Market Perform 19
\nAgiliti Inc AGTI UBS Upgrades Buy 10
\nAgiliti Inc AGTI Morgan Stanley & Co. Target Lowered by Underweight – Underweight 8
\nAkero Therapeutics Inc AKRO H.C. Wainwright Reiterated by Buy – Buy 40
\nAllakos Inc ALLK Barclays Maintains Underweight 1.5
\nAllakos Inc ALLK JMP Securities Maintains Market Outperform 10
\nAlta Equipment Group Inc ALTG Raymond James Target Down Outperform 19.5
\nAlta Equipment Group Inc ALTG Raymond James Target Down Outperform 19.5
\nAlx Oncology Holdings\u00a0 ALXO Stifel Nicolaus Maintains Buy 10
\nAmbrx Biopharma Inc. American Depositary Shares AMAM RBC Maintains Outperform 32
\nAdvanced Micro Devices Inc AMD Roth MKM Initiates Coverage On Buy 125
\nAmplitude Inc AMPL Morgan Stanley & Co. Target Lowered by Equal Weight – Equal Weight 12
\nAltus Power Inc AMPS UBS Maintains Buy 9
\nAltus Power Inc AMPS J.P. Morgan Chase & Co Maintains Overweight 7
\nAbercrombie & Fitch Company ANF Telsey Advisory Group Maintains Outperform 74
\nANSYS Inc ANSS Bank of America Merrill Lynch Downgraded by Buy – Underperform 295
\nAptiv PLC APTV Morgan Stanley & Co. Maintains Equal-Weight 90
\nArko Corp ARKO BMO Capital Markets Downgrades Market Perform 8
\nArtelo Biosciences Inc ARTL H.C. Wainwright Reiterates Buy 5
\nAsure Software Inc ASUR Needham & Company Reiterated by Buy – Buy 20
\nAsure Software Inc ASUR Lake Street Capital Markets Downgraded by Buy – Hold 8
\nAsure Software Inc ASUR Barrington Research Associates Reiterated by Outperform – Outperform 17
\nAsure Software Inc ASUR Stifel Nicolaus Maintains Buy 12
\nAlphatec Holdings Inc ATEC Morgan Stanley & Co. Target Lowered by Overweight – Overweight 17
\nGolden Minerals Company AUMN H.C. Wainwright Maintains Buy 3.1
\nAerovate Therapeutics Inc AVTE Wedbush Securities Reiterated by Outperform 48
\nAlteryx Inc AYX D. A. Davidson & Co. Initiates Coverage On Neutral 40
\nAspen Technology Inc AZPN Robert W. Baird & Co. Upgrades Outperform 202
\nAzenta Inc AZTA Needham & Company Reiterated by Buy – Buy 68
\nAzenta Inc AZTA Stephens Reiterated by Equal Weight – Equal Weight 55
\nBioNTech SE BNTX H.C. Wainwright Maintains Buy 133
\nBorgWarner Inc BWA Morgan Stanley & Co. Maintains Overweight 45
\nBroadwind Energy Inc BWEN H.C. Wainwright Maintains Buy 8
\nCara Therapeutic CARA Piper Jaffray Companies Downgrades Neutral 1
\nCF Industries Holdings Inc CF Barclays Downgrades Underweight 85
\nChampionX Corporation CHX Goldman Sachs & Co. Target Lowered by Neutral – Neutral 32
\nClearside Biomedical Inc CLSD H.C. Wainwright Reiterated by Buy – Buy 6
\nConocoPhillips COP Johnson Rice & Co. Initiated Accumulate 135
\nConocoPhillips COP RBC Maintains Outperform 135
\nCapital Product Partners LP CPLP Stifel Nicolaus Maintains Buy 21
\nCrowdstrike Holdings Inc CRWD J.P. Morgan Chase & Co Maintains Overweight 210
\nCorteva Inc CTVA Barclays Downgrades Equal-Weight 50
\nCuriositystream Inc. CURI Needham & Company Reiterated by Buy – Buy 1.5
\nChevron Corp CVX Mizuho Securities Maintains Buy 195
\nDanaos Corporation DAC Jefferies & Company Reiterated by Buy – Buy 80
\nDocebo Inc DCBO Needham & Company Initiates Coverage On Buy 56
\nDocebo Inc DCBO Needham & Company Target Buy 56
\nChardan NexTech Acquisition 2 Corp DFLI Roth MKM Downgrades Neutral 0.7
\nDick\u2019s Sporting Goods Inc DKS Morgan Stanley & Co. Target Lowered by Overweight – Overweight 145
\nGinkgo Bioworks Holdings DNA Raymond James Downgraded by Outperform – Market Perform 2.5
\nDesign Therapeutics Inc DSGN RBC Maintains Sector Perform 4
\nDesign Therapeutics Inc DSGN Piper Jaffray Companies Downgraded by Overweight – Neutral 6
\nDevon Energy Corporation DVN UBS Maintains Neutral 52
\nElutia Inc. ELUT Cantor Fitzgerald & Co. Maintains Overweight 6
\nEvans Bancorp Inc EVBN Keefe Bruyette & Woods Maintains Market Perform 26.5
\nEvolent Health Inc EVH Truist Financial Maintains Hold 34
\nExpedia Group Inc. EXPE Morgan Stanley & Co. Maintains Equal-Weight 135
\nFathom Digital Manufacturing Corp FATH Needham & Company Maintains Buy 8
\n5E Advanced Materials Inc FEAM Robert W. Baird & Co. Downgrades Neutral 3
\nFair Isaac Corporation FICO Barclays Target Raised by Overweight – Overweight 1234
\nFluor Corporation FLR Barclays Target Raised by Equal Weight – Equal Weight 39
\nFleetcor Technologies Inc FLT Mizuho Securities Maintains Neutral 235
\nFidelity National Financial Inc FNF Stephens Reiterated by Overweight – Overweight 51
\nFREYR Battery SA FREY Morgan Stanley & Co. Downgrades Equal-Weight 2
\nFisker Inc FSR Barclays Target Lowered by Underweight – Underweight 4
\nFortrea Holdings Inc. FTRE Barclays Upgrades Overweight 38
\nGenius Sports Ltd GENI Needham & Company Maintains Buy 9
\nGenius Sports Ltd GENI Benchmark Research Reiterated by Buy – Buy 10
\nGilead Sciences Inc GILD RBC Maintains Sector Perform 77
\nGlobus Medical GMED Morgan Stanley & Co. Maintains Equal-Weight 53
\nGroupon Inc GRPN Goldman Sachs & Co. Target Raised by Sell – Sell 5
\nChart Industries Inc GTLS Goldman Sachs & Co. Target Lowered by Neutral – Neutral 149
\nGuidewire Software Inc GWRE Robert W. Baird & Co. Upgraded by Neutral – Outperform 117
\nGuidewire Software Inc GWRE Stifel Nicolaus Maintains Buy 100
\nHenry Schein Inc HSIC Morgan Stanley & Co. Maintains Underweight 65
\nHenry Schein Inc HSIC Barrington Research Associates Target Lowered by Outperform – Outperform 82
\nHenry Schein Inc HSIC UBS Target Lowered by Neutral – Neutral 75
\nHubSpot Inc HUBS Capital One Financial Initiates Coverage On Overweight 525
\nHydrofarm Holdings Group\u00a0Inc HYFM Stifel Nicolaus Maintains Hold 0.9
\nIntegra LifeSciences Holdings IART CL King & Associates Initiated by Buy 50
\nICF International Inc ICFI Sidoti & Company Downgraded by Buy – Neutral 140
\nICL Israel Chemicals Ltd ICL Barclays Upgrades Overweight 6.5
\nIGM Biosciences Inc IGMS Wedbush Securities Reiterated by Outperform 16
\nIGM Biosciences Inc IGMS Stifel Nicolaus Maintains Buy 25
\nIGM Biosciences Inc IGMS RBC Target Lowered by Sector Perform – Sector Perform 8
\nIM Cannabis Corp IMCC:CA STA Research Target Down Speculative Buy 0.9
\nIM Cannabis Corp IMCC:CA Roth MKM Assigns Buy 1
\nInformatica Inc INFA D. A. Davidson & Co. Initiates Coverage On Neutral 25
\nJoby Aviation JOBY Cantor Fitzgerald & Co. Reiterates Overweight 10
\nKraft Heinz Co KHC Sanford C. Bernstein & Co. Upgrades Outperform 40
\nKamada KMDA H.C. Wainwright Reiterated by Buy – Buy 11
\nKohls Corp KSS Telsey Advisory Group Reiterated by Market Perform – Market Perform 29
\nKezar Life Sciences Inc KZR Wells Fargo & Company Target Lowered by Equal Weight – Equal Weight 2
\nLion Electric Corp LEV Barclays Target Lowered by Equal Weight – Equal Weight 2
\nLifeMD Inc LFMD Cantor Fitzgerald & Co. Target Raised by Overweight – Overweight 9
\nLight & Wonder Inc LNW Susquehanna International Group Maintains Positive 100
\nLucid Diagnostics Inc LUCD Needham & Company Maintains Buy 2.5
\nIntuitive Machines Inc. LUNR Benchmark Research Maintains Buy 10
\nLifeway Foods Inc LWAY Noble Financial Capital Markets Upgraded by Market Perform – Outperform 13
\nLYFT Inc LYFT Morgan Stanley & Co. Maintains Equal-Weight 10.5
\nLegalZoom.com Inc LZ Morgan Stanley & Co. Maintains Underweight 9.5
\nMadrigal Pharmaceuticals Inc MDGL JMP Securities Reiterated by Market Outperform – Market Outperform 383
\nAllscripts Healthcare Solutions Inc MDRX Stephens Reiterated by Equal Weight – Equal Weight 13
\nMeta Platforms Inc. META Stifel Nicolaus Reiterates Buy 405
\nMonday.Com Ltd MNDY UBS Maintains Neutral 185
\nThe Mosaic Company MOS Barclays Upgrades Overweight 42
\nThe Mosaic Company MOS Scotia Capital Maintains Sector Perform 40
\nMP Materials Corp MP Benchmark Research Reiterated by Buy – Buy 30
\nMarvell Technology Group Ltd MRVL Roth MKM Initiates Coverage On Buy 60
\nMicrosoft Corporation MSFT Barclays Target Raised by Overweight – Overweight 425
\nMicrovision Inc MVIS Cantor Fitzgerald & Co. Maintains Neutral 3
\nN-Able Inc NABL BMO Capital Markets Maintains Market Perform 14
\nN-Able Inc NABL J.P. Morgan Chase & Co Maintains Neutral 14.5
\nNeuropace Inc NPCE Morgan Stanley & Co. Maintains Equal-Weight 8
\nNutrien Ltd NTR Barclays Upgrades Overweight 68
\nNutex Health Inc NUTX Benchmark Research Maintains Buy 1.5
\nNavigator Holdings Ltd NVGS Jefferies & Company Reiterated by Buy – Buy 18
\nNew York Community Bancorp Inc NYCB Wedbush Securities Downgrade Neutral – Underperform 8
\nOmniAb Inc. OABI Benchmark Research Reiterated by Buy – Buy 8
\nBlue Owl Capital Corporation OBDC RBC Reiterated by Outperform – Outperform 16
\nOcuphire Pharma Inc OCUP H.C. Wainwright Reiterated by Buy – Buy 20
\nOkta Inc OKTA J.P. Morgan Chase & Co Maintains Neutral 74
\nOutset Medical\u00a0Inc OM Morgan Stanley & Co. Maintains Equal-Weight 5
\nON Semiconductor Corporation ON Roth MKM Initiates Coverage On Buy 75
\nOrganogenesis Holdings Inc ORGO Morgan Stanley & Co. Maintains Equal-Weight 3.5
\nPharvaris BV PHVS Morgan Stanley & Co. Maintains Overweight 32
\nPlug Power Inc PLUG Wells Fargo & Company Target Lowered by Equal Weight – Equal Weight 4
\nPlug Power Inc PLUG Johnson Rice & Co. Reiterated by Buy – Hold 6
\nPlug Power Inc PLUG UBS Target Lowered by Buy – Buy 5
\nPolestar Automotive Holding UK PLC Class A ADS PSNY Barclays Target Lowered by Underweight – Underweight 2
\nPatterson-UTI Energy Inc PTEN Barclays Target Lowered by Overweight – Overweight 16
\nPayPal Holdings Inc PYPL Mizuho Securities Maintains Buy 72
\nDPCM Capital Inc QBTS Benchmark Research Target Lowered by Buy – Buy 2
\nVicarious Surgical Inc. RBOT Canaccord Genuity Downgrades Hold 0.4
\nReady Capital Corp RC Keefe Bruyette & Woods Target Lowered by Market Perform – Market Perform 10
\nReal Good Food Company Inc RGF B. Riley Financial Initiates Coverage On Buy 6
\nRegenxbio Inc RGNX William Blair & Company Reiterated by Neutral 21
\nRoivant Sciences Ltd ROIV J.P. Morgan Chase & Co Maintains Overweight 15
\nSAB Biotherapeutics Inc SABS H.C. Wainwright Maintains Buy 1
\nStar Bulk Carriers Corp SBLK Jefferies & Company Reiterated by Buy – Buy 22
\nSurgery Partners Inc SGRY TD Cowen Upgraded by Market Perform – Outperform 35
\nShake Shack Inc SHAK Stifel Nicolaus Maintains Hold 60
\nJM Smucker Company SJM Sanford C. Bernstein & Co. Upgrades Market Perform 119
\nBeauty Health Co SKIN TD Cowen Downgraded by Outperform – Market Perform 2.5
\nBeauty Health Co SKIN Piper Jaffray Companies Downgraded by Overweight – Underweight 2
\nBeauty Health Co SKIN Canaccord Genuity Downgraded by Buy – Hold 2.5
\nBeauty Health Co SKIN Stifel Nicolaus Maintains Hold 3
\nSKYX Platforms Corp SKYX Benchmark Research Reiterated by Buy – Buy 5
\nSun Country Airlines Holdings Inc SNCY Morgan Stanley & Co. Maintains Equal-Weight 23
\nSphere Entertainment Co. SPHR J.P. Morgan Chase & Co Maintains Neutral 33
\nSpero Therapeutics Inc SPRO H.C. Wainwright Reiterated by Buy – Buy 7
\nSPS Commerce Inc SPSC D. A. Davidson & Co. Initiates Coverage On Buy 200
\nStoneCo\u00a0Ltd STNE Barclays Target Raised by Equal Weight – Equal Weight 12
\nScorpio Tankers Inc STNG J.P. Morgan Chase & Co Maintains Overweight 73
\nSutro Biopharma STRO Wedbush Securities Reiterated by Outperform 12
\nTerritorial Bancorp Inc TBNK Keefe Bruyette & Woods Target Lowered by Market Perform – Market Perform 7
\nTyson Foods Inc TSN Stephens Reiterated by Overweight – Overweight 70
\nTyson Foods Inc TSN BMO Capital Markets Maintains Market Perform 46
\nTyson Foods Inc TSN J.P. Morgan Chase & Co Maintains Neutral 51
\nTake-Two Interactive Software Inc TTWO Deutsche Bank Upgraded by Hold – Buy 175
\nTradeweb Markets Inc TW UBS Maintains Buy 107
\nUnity Biotechnology Inc UBX H.C. Wainwright Reiterated by Buy – Buy 10
\nViridian Therapeutics Inc VRDN JMP Securities Maintains Market Outperform 38
\nVistaGen Therapeutics Inc VTGN Stifel Nicolaus Initiates Coverage On Buy 12
\nWeatherford International PLC WFRD Goldman Sachs & Co. Target Raised by Buy – Buy 113
\nCactus Inc WHD Barclays Maintains Overweight 57
\nWestRock Co WRK Truist Financial Target Lowered by Hold – Hold 40
\nTerawulf Inc WULF Cantor Fitzgerald & Co. Target Lowered by Overweight – Overweight 3
\nBeyond Air Inc XAIR Truist Financial Target Lowered by Buy – Buy 10
\nExxon Mobil Corp XOM Mizuho Securities Maintains Buy 133
\nXperi Corp XPER Rosenblatt Securities Reiterated by Buy – Buy 15
\nExpro Group Holdings NV XPRO Goldman Sachs & Co. Target Lowered by Buy – Buy 22
\nZiff Davis Inc ZD UBS Target Lowered by Neutral – Neutral 71
\nZscaler Inc ZS Stifel Nicolaus Maintains Buy 205
\nZscaler Inc ZS J.P. Morgan Chase & Co Maintains Neutral 190<\/p>\n","protected":false},"excerpt":{"rendered":"

US Analysts Ratings Roundup Abivax SA American Depositary Shares ABVX Leerink Swann Initiated Outperform 20 Abivax SA American Depositary Shares ABVX Morgan Stanley & Co….<\/p>\n","protected":false},"author":9,"featured_media":42710,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"image","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-42705","post","type-post","status-publish","format-image","has-post-thumbnail","hentry","category-blog","post_format-post-format-image"],"acf":[],"yoast_head":"\nAmerican Analyst Ratings November 14th (ALLK) (BNTX) (FSR) (GILD) (FEEM) (NUTX) (ZS) | Stock Target Advisor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-14th-allk-bntx-fsr-gild-feem-nutx-zs\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"American Analyst Ratings November 14th (ALLK) (BNTX) (FSR) (GILD) (FEEM) (NUTX) (ZS)\" \/>\n<meta property=\"og:description\" content=\"US Analysts Ratings Roundup Abivax SA American Depositary Shares ABVX Leerink Swann Initiated Outperform 20 Abivax SA American Depositary Shares ABVX Morgan Stanley & Co....\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-14th-allk-bntx-fsr-gild-feem-nutx-zs\/\" \/>\n<meta property=\"og:site_name\" content=\"Stock Target Advisor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-14T19:57:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2023\/11\/csm_Banner_BioNTech_78f608a3db.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Gillian Lawrence\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:site\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gillian Lawrence\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"9 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-14th-allk-bntx-fsr-gild-feem-nutx-zs\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-14th-allk-bntx-fsr-gild-feem-nutx-zs\/\"},\"author\":{\"name\":\"Gillian Lawrence\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/66cdc3f25fec9be2b72d3a239e22a042\"},\"headline\":\"American Analyst Ratings November 14th (ALLK) (BNTX) (FSR) (GILD) (FEEM) (NUTX) (ZS)\",\"datePublished\":\"2023-11-14T19:57:33+00:00\",\"dateModified\":\"2023-11-14T19:57:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-14th-allk-bntx-fsr-gild-feem-nutx-zs\/\"},\"wordCount\":1901,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"articleSection\":[\"Market News & Insights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-14th-allk-bntx-fsr-gild-feem-nutx-zs\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-14th-allk-bntx-fsr-gild-feem-nutx-zs\/\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-14th-allk-bntx-fsr-gild-feem-nutx-zs\/\",\"name\":\"American Analyst Ratings November 14th (ALLK) (BNTX) (FSR) (GILD) (FEEM) (NUTX) (ZS) | Stock Target Advisor\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\"},\"datePublished\":\"2023-11-14T19:57:33+00:00\",\"dateModified\":\"2023-11-14T19:57:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-14th-allk-bntx-fsr-gild-feem-nutx-zs\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-14th-allk-bntx-fsr-gild-feem-nutx-zs\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-14th-allk-bntx-fsr-gild-feem-nutx-zs\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"American Analyst Ratings November 14th (ALLK) (BNTX) (FSR) (GILD) (FEEM) (NUTX) (ZS)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"name\":\"Stock Target Advisor\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\",\"name\":\"Stock Target Advisor\",\"alternateName\":\"STA\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"contentUrl\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"width\":\"225\",\"height\":\"225\",\"caption\":\"Stock Target Advisor\"},\"image\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\",\"https:\/\/twitter.com\/AdvisorTarget\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/66cdc3f25fec9be2b72d3a239e22a042\",\"name\":\"Gillian Lawrence\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e92fa1f008ae846a29005f505df282c15c605fa5d113c17301039fd5479cb09a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e92fa1f008ae846a29005f505df282c15c605fa5d113c17301039fd5479cb09a?s=96&d=mm&r=g\",\"caption\":\"Gillian Lawrence\"},\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/author\/gillian-lawrence\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"American Analyst Ratings November 14th (ALLK) (BNTX) (FSR) (GILD) (FEEM) (NUTX) (ZS) | Stock Target Advisor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-14th-allk-bntx-fsr-gild-feem-nutx-zs\/","og_locale":"en_US","og_type":"article","og_title":"American Analyst Ratings November 14th (ALLK) (BNTX) (FSR) (GILD) (FEEM) (NUTX) (ZS)","og_description":"US Analysts Ratings Roundup Abivax SA American Depositary Shares ABVX Leerink Swann Initiated Outperform 20 Abivax SA American Depositary Shares ABVX Morgan Stanley & Co....","og_url":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-14th-allk-bntx-fsr-gild-feem-nutx-zs\/","og_site_name":"Stock Target Advisor","article_publisher":"https:\/\/www.facebook.com\/StockTargetAdvisor\/","article_published_time":"2023-11-14T19:57:33+00:00","og_image":[{"width":1920,"height":500,"url":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2023\/11\/csm_Banner_BioNTech_78f608a3db.jpg","type":"image\/jpeg"}],"author":"Gillian Lawrence","twitter_card":"summary_large_image","twitter_creator":"@AdvisorTarget","twitter_site":"@AdvisorTarget","twitter_misc":{"Written by":"Gillian Lawrence","Est. reading time":"9 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-14th-allk-bntx-fsr-gild-feem-nutx-zs\/#article","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-14th-allk-bntx-fsr-gild-feem-nutx-zs\/"},"author":{"name":"Gillian Lawrence","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/66cdc3f25fec9be2b72d3a239e22a042"},"headline":"American Analyst Ratings November 14th (ALLK) (BNTX) (FSR) (GILD) (FEEM) (NUTX) (ZS)","datePublished":"2023-11-14T19:57:33+00:00","dateModified":"2023-11-14T19:57:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-14th-allk-bntx-fsr-gild-feem-nutx-zs\/"},"wordCount":1901,"commentCount":0,"publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"articleSection":["Market News & Insights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-14th-allk-bntx-fsr-gild-feem-nutx-zs\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-14th-allk-bntx-fsr-gild-feem-nutx-zs\/","url":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-14th-allk-bntx-fsr-gild-feem-nutx-zs\/","name":"American Analyst Ratings November 14th (ALLK) (BNTX) (FSR) (GILD) (FEEM) (NUTX) (ZS) | Stock Target Advisor","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website"},"datePublished":"2023-11-14T19:57:33+00:00","dateModified":"2023-11-14T19:57:33+00:00","breadcrumb":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-14th-allk-bntx-fsr-gild-feem-nutx-zs\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-14th-allk-bntx-fsr-gild-feem-nutx-zs\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-november-14th-allk-bntx-fsr-gild-feem-nutx-zs\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.stocktargetadvisor.com\/blog\/"},{"@type":"ListItem","position":2,"name":"American Analyst Ratings November 14th (ALLK) (BNTX) (FSR) (GILD) (FEEM) (NUTX) (ZS)"}]},{"@type":"WebSite","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","name":"Stock Target Advisor","description":"","publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization","name":"Stock Target Advisor","alternateName":"STA","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/","url":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","contentUrl":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","width":"225","height":"225","caption":"Stock Target Advisor"},"image":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/StockTargetAdvisor\/","https:\/\/twitter.com\/AdvisorTarget"]},{"@type":"Person","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/66cdc3f25fec9be2b72d3a239e22a042","name":"Gillian Lawrence","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/e92fa1f008ae846a29005f505df282c15c605fa5d113c17301039fd5479cb09a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e92fa1f008ae846a29005f505df282c15c605fa5d113c17301039fd5479cb09a?s=96&d=mm&r=g","caption":"Gillian Lawrence"},"url":"https:\/\/www.stocktargetadvisor.com\/blog\/author\/gillian-lawrence\/"}]}},"_links":{"self":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/42705","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/comments?post=42705"}],"version-history":[{"count":1,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/42705\/revisions"}],"predecessor-version":[{"id":42711,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/42705\/revisions\/42711"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media\/42710"}],"wp:attachment":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media?parent=42705"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/categories?post=42705"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/tags?post=42705"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}